EE200000391A - Triasiiniühendid kesknärvisüsteemihäirete raviks - Google Patents
Triasiiniühendid kesknärvisüsteemihäirete raviksInfo
- Publication number
- EE200000391A EE200000391A EEP200000391A EEP200000391A EE200000391A EE 200000391 A EE200000391 A EE 200000391A EE P200000391 A EEP200000391 A EE P200000391A EE P200000391 A EEP200000391 A EE P200000391A EE 200000391 A EE200000391 A EE 200000391A
- Authority
- EE
- Estonia
- Prior art keywords
- treatment
- nervous system
- central nervous
- system disorders
- triazine compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9726987.2A GB9726987D0 (en) | 1997-12-22 | 1997-12-22 | Compounds |
| PCT/EP1998/008273 WO1999032462A1 (en) | 1997-12-22 | 1998-12-18 | Triazine compounds for treatment of cns disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200000391A true EE200000391A (et) | 2002-02-15 |
Family
ID=10823992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200000391A EE200000391A (et) | 1997-12-22 | 1998-12-18 | Triasiiniühendid kesknärvisüsteemihäirete raviks |
Country Status (34)
| Country | Link |
|---|---|
| US (2) | US6265405B1 (tr) |
| EP (1) | EP1042304A1 (tr) |
| JP (1) | JP2001526275A (tr) |
| KR (1) | KR20010024800A (tr) |
| CN (1) | CN1284951A (tr) |
| AP (1) | AP2000001846A0 (tr) |
| AR (1) | AR014146A1 (tr) |
| AU (1) | AU753874B2 (tr) |
| BR (1) | BR9814495A (tr) |
| CA (1) | CA2315620A1 (tr) |
| CO (1) | CO5011066A1 (tr) |
| EA (1) | EA200000561A1 (tr) |
| EE (1) | EE200000391A (tr) |
| GB (1) | GB9726987D0 (tr) |
| GT (1) | GT199800203A (tr) |
| HN (1) | HN1998000193A (tr) |
| HR (1) | HRP20000419A2 (tr) |
| HU (1) | HUP0100611A3 (tr) |
| ID (1) | ID25449A (tr) |
| IL (1) | IL136867A0 (tr) |
| IS (1) | IS5542A (tr) |
| JO (1) | JO2065B1 (tr) |
| MA (1) | MA26587A1 (tr) |
| NO (1) | NO20003211L (tr) |
| NZ (1) | NZ505254A (tr) |
| PA (1) | PA8465101A1 (tr) |
| PE (1) | PE20000063A1 (tr) |
| PL (1) | PL341392A1 (tr) |
| SK (1) | SK9592000A3 (tr) |
| SV (1) | SV1998000151A (tr) |
| TR (1) | TR200001970T2 (tr) |
| WO (1) | WO1999032462A1 (tr) |
| YU (1) | YU39600A (tr) |
| ZA (1) | ZA9811725B (tr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0002666D0 (en) | 2000-02-04 | 2000-03-29 | Univ London | Blockade of voltage dependent sodium channels |
| ATE359783T1 (de) * | 2001-12-27 | 2007-05-15 | Ortho Mcneil Pharm Inc | Aroylpyrrolheteroeryl und methanole zur behandlung von störungen des zentralnervensystems |
| ES2323268T3 (es) * | 2002-07-29 | 2009-07-10 | Glaxo Group Ltd | Formulaciones de liberacion prolongada que contienen lamotrigina. |
| JP2006515326A (ja) * | 2003-01-30 | 2006-05-25 | ダイノジェン ファーマシューティカルズ， インコーポレイテッド | 胃腸管障害を処置するためのナトリウムチャネルモジュレーターの使用 |
| AR044503A1 (es) | 2003-03-18 | 2005-09-14 | Merck & Co Inc | Triazoles sustituidos con biarilo como bloqueantes del canal de sodio |
| DE10332472A1 (de) * | 2003-07-16 | 2005-02-03 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ambroxol für die Behandlung von Tinnitus |
| CA2536764C (en) * | 2003-08-25 | 2013-09-17 | Newron Pharmaceuticals, S.P.A. | .alpha.-aminoamide derivatives useful as anti-inflammatory agents |
| US20060115865A1 (en) * | 2004-10-25 | 2006-06-01 | Anlong Ouyang | Lamotrigine analogs |
| GB201111712D0 (en) | 2011-07-08 | 2011-08-24 | Gosforth Ct Holdings Pty Ltd | Pharmaceutical compositions |
| EP3524605B1 (en) * | 2018-02-13 | 2019-11-27 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | New efficient process for the preparation of sitagliptin |
| CN114796146B (zh) * | 2022-04-28 | 2023-03-28 | 上海奥科达医药科技股份有限公司 | 一种拉莫三嗪的缓释制剂及其制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3637688A (en) | 1970-01-09 | 1972-01-25 | American Home Prod | 6-(fluoro and trifluoromethyl phenyl)-3 5-diamino - 1 2 4 - triazines and substituted - 6 - phenylalkyl-3,5-diamino-1 2 4-triazines |
| EP0021120B1 (en) | 1979-06-01 | 1983-04-06 | The Wellcome Foundation Limited | 3,5-diamino-1,2,4-triazine derivatives, process for preparing such compounds and pharmaceutical compositions containing them |
| AU530999B2 (en) | 1979-06-01 | 1983-08-04 | Wellcome Foundation Limited, The | Substituted amino triazines and their use in treatment of cns disorders |
| IT1145308B (it) | 1979-08-16 | 1986-11-05 | Wellcome Found | Composti aromatici sostituiti |
| GB8328757D0 (en) | 1983-10-27 | 1983-11-30 | Wellcome Found | Chemical compounds |
| GB9012316D0 (en) | 1990-06-01 | 1990-07-18 | Wellcome Found | Pharmacologically active cns compounds |
| GB9012311D0 (en) | 1990-06-01 | 1990-07-18 | Wellcome Found | Pharmacologically active cns compounds |
| GB9012312D0 (en) | 1990-06-01 | 1990-07-18 | Wellcome Found | Pharmacologically active cns compounds |
| GB9203483D0 (en) | 1992-02-19 | 1992-04-08 | Wellcome Found | Anti-inflammatory compounds |
| JP3439211B2 (ja) | 1992-06-12 | 2003-08-25 | ザ ウエルカム ファウンデーション リミテッド | 薬物に対する依存性，耐性および感作の処置および予防における３，５−ジアミノ−６−（２，３−ジクロロフェニル）−１，２，４−トリアジン イセチオネートの使用 |
| AU5704594A (en) | 1992-12-18 | 1994-07-19 | Wellcome Foundation Limited, The | Pyrimidine, pyridine, pteridinone and indazole derivatives as enzyme inhibitors |
| US5866597A (en) | 1993-03-19 | 1999-02-02 | Glaxo Wellcome Inc. | Use of triazine compounds for the treatment of memory and learning disorders |
| GB9305692D0 (en) | 1993-03-19 | 1993-05-05 | Wellcome Found | Therapeutic triazine compounds and use |
| GB9426448D0 (en) * | 1994-12-30 | 1995-03-01 | Wellcome Found | Process |
| FR2741879A1 (fr) | 1995-12-05 | 1997-06-06 | Esteve Labor Dr | Derives de fluorophenyl-triazines et pyrimidines, leur preparation et leur application en tant que medicament |
-
1997
- 1997-12-22 GB GBGB9726987.2A patent/GB9726987D0/en not_active Ceased
-
1998
- 1998-12-18 AR ARP980106526A patent/AR014146A1/es not_active Application Discontinuation
- 1998-12-18 EE EEP200000391A patent/EE200000391A/xx unknown
- 1998-12-18 PL PL98341392A patent/PL341392A1/xx unknown
- 1998-12-18 NZ NZ505254A patent/NZ505254A/en unknown
- 1998-12-18 AU AU24147/99A patent/AU753874B2/en not_active Ceased
- 1998-12-18 CN CN98813745A patent/CN1284951A/zh active Pending
- 1998-12-18 SK SK959-2000A patent/SK9592000A3/sk unknown
- 1998-12-18 EA EA200000561A patent/EA200000561A1/ru unknown
- 1998-12-18 HU HU0100611A patent/HUP0100611A3/hu unknown
- 1998-12-18 ID IDW20001416A patent/ID25449A/id unknown
- 1998-12-18 YU YU39600A patent/YU39600A/sh unknown
- 1998-12-18 KR KR1020007006947A patent/KR20010024800A/ko not_active Application Discontinuation
- 1998-12-18 BR BR9814495-2A patent/BR9814495A/pt not_active IP Right Cessation
- 1998-12-18 WO PCT/EP1998/008273 patent/WO1999032462A1/en not_active Application Discontinuation
- 1998-12-18 CA CA002315620A patent/CA2315620A1/en not_active Abandoned
- 1998-12-18 EP EP98966635A patent/EP1042304A1/en not_active Withdrawn
- 1998-12-18 IL IL13686798A patent/IL136867A0/xx unknown
- 1998-12-18 US US09/582,058 patent/US6265405B1/en not_active Expired - Fee Related
- 1998-12-18 SV SV1998000151A patent/SV1998000151A/es unknown
- 1998-12-18 AP APAP/P/2000/001846A patent/AP2000001846A0/en unknown
- 1998-12-18 JP JP2000525399A patent/JP2001526275A/ja active Pending
- 1998-12-18 TR TR2000/01970T patent/TR200001970T2/tr unknown
- 1998-12-18 CO CO98075403A patent/CO5011066A1/es unknown
- 1998-12-21 PA PA19988465101A patent/PA8465101A1/es unknown
- 1998-12-21 JO JO19982065A patent/JO2065B1/en active
- 1998-12-21 PE PE1998001255A patent/PE20000063A1/es not_active Application Discontinuation
- 1998-12-21 ZA ZA9811725A patent/ZA9811725B/xx unknown
- 1998-12-22 GT GT199800203A patent/GT199800203A/es unknown
- 1998-12-22 MA MA25403A patent/MA26587A1/fr unknown
-
1999
- 1999-12-21 HN HN1998000193A patent/HN1998000193A/es unknown
-
2000
- 2000-06-20 IS IS5542A patent/IS5542A/is unknown
- 2000-06-21 NO NO20003211A patent/NO20003211L/no unknown
- 2000-06-21 HR HR20000419A patent/HRP20000419A2/hr not_active Application Discontinuation
-
2001
- 2001-07-06 US US09/899,198 patent/US6465461B1/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE04280B1 (et) | Imidasopürimidiinid ja imidasopüridiinid neuroloogiliste häirete käitlemiseks | |
| ID28529A (id) | Vinileter heterosiklik untuk gangguan neurologi | |
| DE69925571D1 (de) | Sulphonamid-derivate zur behandlung von störungen des zentralnervensystems | |
| IS5113A (is) | Notkun antagónista CB1-viðtaka til meðhöndlunar löngunartruflana | |
| DK0769947T3 (da) | Indolinonforbindelser til behandling af sygdom | |
| NO20005864D0 (no) | Quinasoler til behandling av hjernesvulst | |
| DK0830864T3 (da) | Kombinationsbehandling til behandling af psykoser | |
| NO20004688D0 (no) | Terapi ved østrogenassosierte lidelser | |
| NO20005884L (no) | Kombinasjonsterapi for behandling av bipolare forstyrrelser | |
| IL155589A0 (en) | Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders | |
| FI980387A0 (fi) | Foerfarande foer att foerhindra bildning av utfaellningar i svartlutsindunstare | |
| EE200000391A (et) | Triasiiniühendid kesknärvisüsteemihäirete raviks | |
| ID27214A (id) | Triazolopiridina untuk pengobatan gangguan trombosis | |
| BR9712030A (pt) | Uso de benzopiranÄis para o tratamento de desordens neurolÄgicas | |
| DK0935598T3 (da) | 5-heteroatom-alkylsubstituerede 3-oxopyrido(1,2-a)benzimidazol-4-carboxamidderivater egnede til behandling af sygdomme i centralnervesystemet | |
| NO991734D0 (no) | Pyrazolinoner for behandling av potensforstyrrelser | |
| ATE287718T1 (de) | Benzenesulfonamide derivate in kombination mit beta-blockern zur behandlung von störungen des autonomen nervensystems | |
| IS4569A (is) | Bensamíð til að meðhöndla taugahrörnunarsjúkdóma | |
| ID21920A (id) | 4-6-fluoro-(1h)-indol-3-il-1,2,3,6-tetrahidropirin tersubstitusi untuk pengobatan gangguan cns | |
| NO20002481D0 (no) | Kombinasjonsterapi for behandling av AIDS | |
| DK1011678T3 (da) | Anvendelse af mecamylamin til behandling af nikotin-responsive neuropsykiatriske lidelser | |
| NO20012538D0 (no) | Anvendelse av N-substituerte azabicycloalkanderivater for behandling av forstyrrelser i sentralnervesystemet | |
| UA25221A (uk) | Спосіб лікуваhhя розладів цеhтральhої hервової системи | |
| IL136949A0 (en) | 1,4-diazacycloheptane derivatives for the treatment of neurological disorders | |
| IL121597A0 (en) | Novel optically pure amines for the treatment of central nervous system disorders |